First Light Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
First Light Asset Management, LLC
- $1.02 Billion
- Q4 2024
A detailed history of First Light Asset Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 763,607 shares of RARE stock, worth $32.8 Million. This represents 3.14% of its overall portfolio holdings.
Number of Shares
763,607
Previous 755,102
1.13%
Holding current value
$32.8 Million
Previous $41.9 Million
23.41%
% of portfolio
3.14%
Previous 3.65%
Shares
22 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$431 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$240 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$184 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$117 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$108 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.01B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...